Dry Eye Drugs and Devices Treatment Market

Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry eye, and the Others one is evaporative dry eye. Dry eye syndrome is one of the most common eye disorders around the world and is particularly common in the geriatric demographic. Reduction in the production of tears due to aging is the primary cause of dry eye syndrome among the elderly.
Dry Eye Drugs and Devices Treatment Market contains market size and forecasts of Dry Eye Drugs and Devices Treatment in Global, including the following market information:
Global Dry Eye Drugs and Devices Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Dry Eye Drugs and Devices Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotic Drops Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dry Eye Drugs and Devices Treatment include Novartis, Merck, Johnson & Johnson, EyeGate Pharmaceuticals, Allergan, Takeda, Jianfeng Group, Bausch Health and Santen Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dry Eye Drugs and Devices Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dry Eye Drugs and Devices Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, by Type, 2021 (%)
Antibiotic Drops
Hormone Drops
Artificial Tears
Others
Global Dry Eye Drugs and Devices Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Dry Eye Drugs and Devices Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dry Eye Drugs and Devices Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Dry Eye Drugs and Devices Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Merck
Johnson & Johnson
EyeGate Pharmaceuticals
Allergan
Takeda
Jianfeng Group
Bausch Health
Santen Pharmaceutical
Senju Pharmaceutical